Cargando…
Identification of potentially anti-COVID-19 active drugs using the connectivity MAP
Drug repurposing can be an interesting strategy for an emergency response to the severe acute respiratory syndrome-coronavirus-2, (SARS-COV-2), the causing agent of the coronavirus disease-19 (COVID-19) pandemic. For this, we applied the Connectivity Map (CMap) bioinformatic resource to identify dru...
Autores principales: | Bonnet, Raphaël, Mariault, Lee, Peyron, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794112/ https://www.ncbi.nlm.nih.gov/pubmed/35085325 http://dx.doi.org/10.1371/journal.pone.0262751 |
Ejemplares similares
-
Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018) -
New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020) -
Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
por: Li, Zhonglin, et al.
Publicado: (2020) -
Probabilistic drug connectivity mapping
por: Parkkinen, Juuso A, et al.
Publicado: (2014) -
Identification of small molecules as novel anti-adipogenic compounds based on Connectivity Map
por: Zhang, Shuang, et al.
Publicado: (2022)